Product name | Bb Plus MicroVue™ Quidel®Bb fragments of Factor B of the Alternative Complement Pathway |
Cat-Nr. | A027 |
Range | 0.06 - 0.65 µg/ml |
Sensitivity | LOD: 0.018 µg/ml; LLOQ: 0.033 µg/ml |
Incubation time | 1,5 Stunden |
Sample volume | 100 µl (after dilution 1:10 for plasma, 1:20 for serum) |
Sample type | Serum and plasma |
Sample preparation | Specimens should be tested immediately or stored at 4 ºC or on ice until assayed. This should not exceed four hours. For long-term storage, freeze at -70ºC within two hours after collection. |
Reference values | in Plasma 0.49 - 1.42 µg/ml (+2 SD) in Serum 0.80 - 6.26 µg/ml (+2 SD) |
Species | Human, cynomolgus macaque, baboon, rhesus macaque |
Specificity | Monoclonal mouse-antibody, specifically binds Bb. |
Tests | 96 Tests |
Method | ELISA |
Intended use | The Bb fragment enzyme immunoassay measures the amount of the complement fragment of Bb, an activation fragment of Factor B in human plasma or serum, as well as in other biological fluids, experimental samples or mixtures. This measurement allows a quantitative assessment of the extent of activation of the alternative pathway of complement in the test sample. Measurement of alternate pathway activation aids in the diagnosis of several kidney diseases (e.g. chronic Glomerulonephritis, lupus nephritis), as well as several skin diseases (e.g. dermititis herpetiformis and pemphigus vulgaris). Other diseases in which activation of the alternat pathway of complement has been observed include rheumatoid arthritis, sickle cell anemia, and gram-negative bacterial infections. |
Product informations | Kit Instructions (PDF 192,7 kB) Cross-reaction all species (PDF 74,6 kB) Measurement of Complement Activation in Human Disease (PDF 4,6 MB) Hemocompatibility (PDF 6,4 MB) Information (PDF 679,7 kB) |
Back to overview
tecomedical总部位于瑞士的TECOmedical Group在德国,法国和比荷卢三国设有子公司,是医学和兽医诊断,生物安全和环境测试领域体外专业测试系统的领先提供商。此外,我们与意见领袖合作开发或评估新的测试系统,或为制药,CRO和研究组织提供服务。